Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-28

Clinical Trial Update: Initiating Early Control of Migraine Pain and Associated Symptoms [Phase 3]

View source ↗

Summary

Phase 3 migraine trial completed and results posted. The study evaluated early control of migraine pain and associated symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2026-01-28